Interleukin-2 for Refractory Chronic Spontaneous Urticaria

NCT06924762 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

124

Enrollment

OTHER

Sponsor class

Conditions

Chronic Spontaneous Uriticaria

Interventions

DRUG: Placebo intramuscular injection
DRUG: Human interleukin-2 (I) intramuscular injection

Sponsor

Second Xiangya Hospital of Central South University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]